Kezhen Lv

79 Qingchun Road
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Whole-exome sequencing of FFPE samples reveals mutations associated with Luminal A breast cancer recurrence.

Whole-exome sequencing of FFPE samples reveals mutations associated with Luminal A breast cancer recurrence.

Journal: BMC biotechnology
Published: July 24, 2025

Pegylated Liposomal Doxorubicin Versus Epirubicin as Adjuvant Therapy for Stage I-III Breast Cancer.

Pegylated Liposomal Doxorubicin Versus Epirubicin as Adjuvant Therapy for Stage I-III Breast Cancer.

Journal: Frontiers in genetics
Published: July 23, 2021

The Expression Profiles of MicroRNA Let-7a in Peripheral Blood Mononuclear Cells from Patients of Gastric Cancer with Neoadjuvant Chemotherapy.

The Expression Profiles of MicroRNA Let-7a in Peripheral Blood Mononuclear Cells from Patients of Gastric Cancer with Neoadjuvant Chemotherapy.

Journal: Clinical laboratory
Published: May 09, 2018

Bcl-2 promotes metastasis through the epithelial-to-mesenchymal transition in the BCap37 medullary breast cancer cell line.

Bcl-2 promotes metastasis through the epithelial-to-mesenchymal transition in the BCap37 medullary breast cancer cell line.

Journal: Oncology letters
Published: June 06, 2017

KLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth.

KLF4 downregulates hTERT expression and telomerase activity to inhibit lung carcinoma growth.

Journal: Oncotarget
Published: January 07, 2016

Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer.

Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer.

Journal: OncoTargets and therapy
Published: October 21, 2014

MicroRNA-185 inhibits proliferation by targeting c-Met in human breast cancer cells.

MicroRNA-185 inhibits proliferation by targeting c-Met in human breast cancer cells.

Journal: Experimental and therapeutic medicine
Published: April 02, 2014

Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines.

Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines.

Journal: Oncology reports
Published: February 14, 2014

EIF5A2 is a novel chemoresistance gene in breast cancer.

EIF5A2 is a novel chemoresistance gene in breast cancer.

Journal: Breast cancer (Tokyo, Japan)
Published: November 01, 2013

Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.

Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicin.

Journal: Experimental cell research
Published: April 22, 2013

Lin28 mediates radiation resistance of breast cancer cells via regulation of caspase, H2A.X and Let-7 signaling.

Lin28 mediates radiation resistance of breast cancer cells via regulation of caspase, H2A.X and Let-7 signaling.

Journal: PloS one
Published: November 29, 2012

Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells.

Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells.

Journal: PloS one
Published: January 30, 2012
Showing 1-12 of 13

Last Updated: 09/26/2026